 | Genmab A/S (OTCMKTS:GNMSF) Reaches New 52-Week High at $438.50
americanbankingnews.com - January 14 at 7:20 PM |
| Genmab A/S (OTCMKTS:GNMSF) Short Interest Up 97.4% in December
americanbankingnews.com - January 14 at 6:08 AM |
 | Genmab Achieves USD 40 Million Milestone in Collaboration with AbbVie
finance.yahoo.com - January 13 at 9:46 AM |
| Genmab A/S (OTCMKTS:GNMSF) Share Price Crosses Above Fifty Day Moving Average of $394.24
americanbankingnews.com - January 13 at 4:56 AM |
| Genmab to Present at the 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 6 at 12:19 PM |
| Genmab A/S (OTCMKTS:GNMSF) Hits New 12-Month High at $430.18
americanbankingnews.com - January 5 at 6:42 PM |
| Genmab (GMAB) Begins Phase III Study on Cervical Cancer Drug
finance.yahoo.com - January 5 at 4:10 PM |
| Genmab A/S (OTCMKTS:GNMSF) Reaches New 52-Week High at $410.41
americanbankingnews.com - December 30 at 6:38 PM |
| AbbVie (ABBV) Outperforms Industry Year to Date: Here's Why
finance.yahoo.com - December 28 at 1:42 PM |
| Genmab A/S (OTCMKTS:GNMSF) Stock Crosses Above Fifty Day Moving Average of $380.11
americanbankingnews.com - December 25 at 4:22 AM |
|
| Stocks Showing Improved Relative Strength: Revance Therapeutics
finance.yahoo.com - December 23 at 2:21 PM |
| Sarepta Therapeutics Sees Relative Strength Rating Improve To 74
finance.yahoo.com - December 9 at 3:15 PM |
| Sarepta Therapeutics Earns Relative Strength Rating Upgrade
finance.yahoo.com - December 7 at 3:47 PM |
| Genmab Announces that Janssen has Submitted a Biologics License Application to U.S. FDA for Amivantamab in Non-small Cell Lung Cancer
finance.yahoo.com - December 3 at 4:14 PM |
| Genmab Announces Enapotamab Vedotin Update
finance.yahoo.com - November 24 at 11:23 AM |
| Genmab to Present at Jefferies Virtual London Healthcare Conference
finance.yahoo.com - November 10 at 9:10 AM |
 | Genmab A/S (GMAB) Q3 2020 Earnings Call Transcript
fool.com - November 5 at 4:37 AM |
| Genmab Announces IFM, HOVON and Janssen Achieve Positive Topline Results in Second Part of Phase 3 CASSIOPEIA Study of Daratumumab in Multiple Myeloma at Pre-planned Interim Analysis
finance.yahoo.com - October 21 at 6:10 PM |
| Genmab and Seattle Genetics Present Data from Tisotumab Vedotin innovaTV 204 Pivotal Trial in Recurrent or Metastatic Cervical Cancer at ESMO Virtual Congress 2020
finance.yahoo.com - September 21 at 1:27 PM |
| Genmab Announces that Janssen has Submitted a Supplemental Biologics License Application to U.S. FDA for use of DARZALEX FASPRO™ (daratumumab and hyaluronidase-fihj) in Patients with Light-chain (AL) Amyloidosis
finance.yahoo.com - September 10 at 8:34 AM |
| Genmab to Present at Morgan Stanley 18th Annual Global Healthcare Conference
finance.yahoo.com - September 9 at 1:01 PM |
| Genmab Announces Late-Breaking Oral Presentation of Phase 2 innovaTV 204 Study at the ESMO Virtual Congress 2020
finance.yahoo.com - August 26 at 6:39 PM |
| Kura Oncology Clears Key Benchmark, Hitting 90-Plus RS Rating
finance.yahoo.com - August 26 at 1:39 PM |
| Genmab Announces Plan to Transition Arzerra® (ofatumumab) to an Oncology Access Program for Chronic Lymphocytic Leukemia Patients in the U.S.
finance.yahoo.com - August 20 at 5:50 PM |
| Genmab Announces Janssen Granted U.S. FDA Approval for DARZALEX® (daratumumab) in Combination with Carfilzomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma
finance.yahoo.com - August 20 at 5:50 PM |
| Genmab A/S (GMAB) Q2 2020 Earnings Call Transcript
finance.yahoo.com - August 12 at 10:50 PM |
| Genmab Announces Financial Results for the First Half of 2020
finance.yahoo.com - August 12 at 12:50 PM |
| Genmab (GMAB) to Report Q2 Earnings: What's in the Cards?
finance.yahoo.com - August 3 at 12:00 PM |
|
| AbbVie Shares Climb After Adjusted Profit Beats Analyst Views
finance.yahoo.com - July 31 at 10:07 AM |
| Genmab Announces Net Sales of DARZALEX® for the Second Quarter of 2020
finance.yahoo.com - July 16 at 7:52 AM |
| Can Genmab AS Sponsored ADR (GMAB) Run Higher on Rising Earnings Estimates?
finance.yahoo.com - June 16 at 1:14 PM |
| How Does Genmab's (CPH:GMAB) P/E Compare To Its Industry, After Its Big Share Price Gain?
finance.yahoo.com - May 13 at 3:00 AM |
 | Genmab A/S 2020 Q1 - Results - Earnings Call Presentation
seekingalpha.com - May 6 at 4:09 PM |
| Should We Worry About Genmab A/S's (CPH:GMAB) P/E Ratio?
finance.yahoo.com - April 15 at 7:51 AM |
| Is Now The Time To Put Genmab (CPH:GMAB) On Your Watchlist?
finance.yahoo.com - February 26 at 6:20 AM |
| Genmab A/S (GMAB) Q4 2019 Earnings Call Transcript
www.fool.com - February 19 at 11:07 PM |
| Genmab A/S 2019 Q4 - Results - Earnings Call Presentation
seekingalpha.com - February 19 at 2:51 PM |
| European advisory group backs expanded label for J&J's Darzalex
seekingalpha.com - October 18 at 11:09 AM |
| What Should Investors Know About The Future Of Genmab A/S's (CPH:GMAB)?
finance.yahoo.com - August 14 at 5:19 PM |
| Genmab up 2% in Europe on Q2 Darzalex sales
seekingalpha.com - July 16 at 10:28 AM |
| Janssen files U.S. application for subcutaneous Darzalex
seekingalpha.com - July 12 at 4:51 PM |
| Genmab teams up with BliNK Biomedical to develop bispecific antibodies
seekingalpha.com - July 12 at 10:20 AM |
| J&J's Darzalex shows treatment effect in mid-stage study in certain MM patients
seekingalpha.com - July 8 at 4:56 PM |
| BlackRock cuts stake in Genmab
seekingalpha.com - June 25 at 5:16 PM |
| Genmab A/S 2019 Q1 - Results - Earnings Call Slides
seekingalpha.com - May 13 at 5:38 PM |
| Why Earnings Season Could Be Great for Genmab (GNMSF)
finance.yahoo.com - May 13 at 5:38 PM |
 | Global Blood (GBT) Reports Narrower-Than-Expected Loss in Q1
www.msn.com - May 10 at 5:18 PM |
| Amicus' (FOLD) Earnings & Revenues Miss Estimates in Q1
finance.yahoo.com - May 9 at 5:24 PM |
| What's in the Cards for AcelRx (ACRX) This Earnings Season?
finance.yahoo.com - May 7 at 5:28 PM |
| Seattle Genetics' Adcetris Progresses Well Amid Competition
finance.yahoo.com - April 11 at 11:49 AM |
